Study to Evaluate Antidepressant as Potential COVID-19 Treatment: St. Louis School of Medicine
April 14, 2020
April 14, 2020
ST. LOUIS, Missouri, April 14 -- The Washington University St. Louis School of Medicine issued the following news release:
Researchers at Washington University School of Medicine in St. Louis are launching a clinical trial in patients who have tested positive for COVID-19 but who are not sick enough to be hospitalized. The trial is investigating whether the antidepressant medication fluvoxamine, which is currently used to treat patients with obsessive-compulsive disorder (OCD), can . . .
Researchers at Washington University School of Medicine in St. Louis are launching a clinical trial in patients who have tested positive for COVID-19 but who are not sick enough to be hospitalized. The trial is investigating whether the antidepressant medication fluvoxamine, which is currently used to treat patients with obsessive-compulsive disorder (OCD), can . . .